Immunomedics CFO Pleads Guilty To Insider Trading About Breast Cancer Drug

Mealey's (May 25, 2023, 8:30 AM EDT) -- NEWARK, N.J. — The former chief financial officer (CFO) of Immunomedics Inc. has pleaded guilty to one charge of insider trading, admitting that he gave insider information about a new drug development and then made about $213,000 in profit off of a $65,000 purchase of company stock....